NZ Medsafe Approves Pfizer Vaccine for Children Aged 5-11 Years
Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…
Synopsis- The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart, the health…
Summary: The clinical trial results show that the vaccine is safe and effective in this in this age group, it will thus…
Summary – French health authorities have approved the use of an antibody treatment made by AstraZeneca for high-risk people who show resistance…
Summary : With the FDA’s emergency use authorization today of AstraZeneca’s long-acting antibody cocktail, the roughly 2% of U.S. residents who are…
Summary : The company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld,…
Summary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…
Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
Synopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
Synopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
The European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…